Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair

Retrieved on: 2021-04-13 12:17:28

Tags for this article:

Medical specialties

Clinical medicine

Health care

Monoclonal antibodies

Click the tags to see associated articles and topics

Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair. View article details on hiswai:

Excerpt

Levi Garraway, Roche's chief medical officer and head of Global Product Development, said the new indication for Xolair reflects the commitment of ...

Article found on: www.biospace.com

View Original Article